Showing results (321-330 of 1,086) with videos related to
Sort By:
Pageof 109
Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.Circulation. Cardiovascular Interventions|March 26, 2025
Predictive Value of Platelet FcγRIIa in Patients Treated With PCI Compared With Medical Therapy Alone After Myocardial InfarctionDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.The American Journal of Cardiology|February 17, 2017
Comparison of Platelet Reactivity in Black Versus White Patients With Acute Coronary Syndromes After Treatment With TicagrelorMichael A Gaglia, Michael J Lipinski, Thibault Lhermusier, et al.Journal of Thrombosis and Thrombolysis|August 29, 2022
Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective, randomized, crossover studyFrancesco Franchi, David J Schneider, Jayne Prats, et al.Journal of the American College of Cardiology|June 16, 2012
Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trialMatthew J Price, James S Walder, Brian A Baker, et al.Circulation. Cardiovascular Interventions|September 26, 2013
Effect on platelet reactivity from a prasugrel loading dose after a clopidogrel loading dose compared with a prasugrel loading dose alone: Transferring From Clopidogrel Loading Dose to Prasugrel Loading Dose in Acute Coronary Syndrome Patients (TRIPLET): a randomized controlled trialJean G Diodati, Jorge F Saucedo, John K French, et al.The Journal of Invasive Cardiology|July 23, 2025
Prognostic implications over time of platelet FcɣRIIa expression in patients with myocardial infarction: a secondary analysisDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.Journal of the American College of Cardiology|May 26, 2012
Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) studyMatthew J Price, Sarah S Murray, Dominick J Angiolillo, et al.Journal of Clinical Medicine|November 11, 2022
Escalation and De-Escalation of Antiplatelet Therapy after Acute Coronary Syndrome or PCI: Available Evidence and Implications for PracticeFelice Gragnano, Antonio Capolongo, Fabrizia Terracciano, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 17, 2026
Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial InfarctionDavid J Schneider, Sean R McMahon, Dominick J Angiolillo, et al.Pageof 109